Tevogen Bio Holdings (TVGN) Non Operating Investment Income (2022 - 2023)
Tevogen Bio Holdings (TVGN) reported Non Operating Investment Income of $317365.0 for Q4 2023, down 88.42% on a YoY basis from $2.7 million in Q4 2022, and down 5.12% quarter-over-quarter from $334475.0 in Q3 2023.
Tevogen Bio Holdings (TVGN) Non Operating Investment Income (2022 - 2023) Analysis & Trends
Tevogen Bio Holdings has reported Non Operating Investment Income for 2 years, with the latest figure at $317365.0 in Q4 2023.
- For the quarter ending Q4 2023, Non Operating Investment Income fell 88.42% year-over-year to $317365.0; the trailing twelve-month figure through Dec 2023 stood at $2.7 million (down 44.74% YoY), and the FY2023 full-year result was $2.7 million, down 44.74% from the prior year.
- Non Operating Investment Income for Q4 2023 stood at $317365.0, down from $334475.0 in the prior quarter.
- The five-year high for Non Operating Investment Income was $2.7 million in Q4 2022, with the low at $140891.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 230,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Tevogen Bio Holdings | 173.69 Mn | 173.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 317,365.00 |
| Dec 31, 2023 | 317,365.00 |
| Sep 30, 2023 | 334,475.00 |
| Sep 30, 2023 | 334,475.00 |
| Jun 30, 2023 | 302,524.00 |
| Jun 30, 2023 | 302,524.00 |
| Mar 31, 2023 | 1.78 Mn |
| Mar 31, 2023 | 1.78 Mn |
| Dec 31, 2022 | 2.74 Mn |
| Dec 31, 2022 | 2.74 Mn |
| Sep 30, 2022 | 1.74 Mn |
| Sep 30, 2022 | 1.74 Mn |
| Jun 30, 2022 | 327,833.00 |
| Jun 30, 2022 | 327,833.00 |
| Mar 31, 2022 | 140,891.00 |
| Mar 31, 2022 | 140,891.00 |